Ro KhannaBuy
ABBV Common Stock · Transaction Jun 2, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
XNYS · ABBV
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
ABBVIE INC.
PHARMACEUTICAL PREPARATIONS
$261.72
Veridion Score
BETAHIGH CONF · 6 of 6 factors measuredWed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET · ABBV
MethodologyABBV
ABBVIE INC.
Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
68/ 100
Veridion Score
Upper range · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ABBV moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About ABBVIE INC.
PHARMACEUTICAL PREPARATIONSListed since
2012
Employees
57K
Country
US
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$261.72
Last session
Day high
$261.72
Last session
Day low
$261.72
Last session
Previous close
$261.72
52W high
$265.97
-1.60% from high
52W low
$197.38
94% of range
Market cap
$462.5B
P/E
86.09×
EPS
$3.04
Beta
-0.63
Shares out
1.8B
Avg volume
5M
VWAP
$261.72
Last session
Price history computed in-house
1W
+1.38%
1M
+7.35%
3M
+15.18%
1Y
+23.53%
YTD
+14.54%
SMA 50 $253.71 · above
SMA 200 $228.09 · above
52W position 94%
ABBV overview
Veridion Score
68
Registered · 2026-09-02
6 of 6 factors measured
Latest receipt rows
5
Ro Khanna · Purchase
13F holders
4
Vanguard Group, Inc.
Receipt-backed holder profiles
SEC industry peers
ABBV peers
Related filings and maps
Public disclosures
Congress activity in ABBV
Official filing ↗
1 JTAbbVie Inc. Common Stock · Transaction May 27, 2026 · Filed Jun 3, 2026 · $1,001 to $15,000
Ro KhannaBuy
ABBV Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $15,001 to $50,000
AbbVie Inc. Common Stock · Transaction May 5, 2026 · Filed Jun 3, 2026 · $1,001 to $15,000
Ro KhannaBuy
ABBV Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · $15,001 to $50,000
Federal contracts
ABBV contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABBV in this window.
Lobbying spend
ABBV lobbying filings, year to date.
Registered lobbying filings matched to ABBVIE INC..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABBV in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ABBV.
Options
Sovereign unlock shows live options positioning for ABBV.